ASPR has released a new side-by-side overview of COVID-19 monoclonal antibody therapeutics currently authorized in the U.S. for treatment of mild-moderate COVID-19. This quick reference provides information about each product’s efficacy, dosing, authorized use, and other important patient care considerations.
More NACCHO Blogs
The Preparedness Brief provides updates and information from NACCHO’s public health preparedness portfolio.
Stories from the Field
Stories from the Field provides a means for local health departments to share their experiences and demonstrate the value of public health.